LifePoint Announces Kevin McNerney as Vice President Operations
September 08, 2003 08:30 ET
|
LifePoint, Inc.
ONTARIO, Calif., Sept. 8, 2003 (PRIMEZONE) -- LifePoint, Inc. (AMEX:LFP), a leader in non-invasive drug diagnostic technologies and solutions, today announced that Mr. Kevin McNerney has joined the...
Immune Network Gains Access to Organon Compound Library and Continues Third Generation Dapsone Drug Discovery Progam
April 25, 2003 13:48 ET
|
Immune Network Ltd.
VANCOUVER, B.C., April 25, 2003 (PRIMEZONE) -- Immune Network Ltd. (OTCBB:IMMFF) reports progress with its research and development of new anti-inflammatory compounds, some of which are closely...
Emerging Company Report: LifePoint's Non-Invasive Drug Diagnostic Technologies
August 16, 2002 10:44 ET
|
LifePoint, Inc.
HOLLYWOOD, Calif., Aug. 16, 2002 (PRIMEZONE) -- Emerging Company Report is the nationally syndicated television program profiling emerging-growth companies (http://www.emergingcompany.com), featuring...
CTT Licensee Palatin Technologies to Begin Clinical Development of PT-141 Erectile Dysfunction Drug
June 26, 2000 09:16 ET
|
Competitive Technologies, Inc.
FAIRFIELD, Conn.,June 26, 2000 (PRIMEZONE) - Competitive Technologies, Inc. (AMEX:CTT) today confirmed that its licensee, Palatin Technologies, Inc. (AMEX:PTN), plans to begin the clinical...
Situs Corporation Receives Patent Allowances for Proprietary UROS Infusor(Tm) and for Overactive Bladder Drug
April 18, 2000 08:20 ET
|
Situs Corporation
SOLANA BEACH, Calif., April 18, 2000 (PRIMEZONE) -- Situs Corporation, a pioneer in intravesical drug delivery, today announced it has received from the US Patent and Trademark Office notices of...
Situs Corp. to Initiate Phase 1-2 Study of its UROS Infusor Intravesical Drug Delivery Device
January 25, 2000 08:00 ET
|
Situs Corporation
SOLANA BEACH, Calif., Jan. 25, 2000 (PRIMEZONE) -- Situs Corp. today announced that it has received FDA approval to begin Phase 1-2 clinical testing of its intravesical drug delivery device, the...
Situs Files Investigational Drug Application for UROS( A New, Innovative Drug Delivery System
November 02, 1999 08:15 ET
|
Situs Corporation
SOLANA BEACH, Calif., Nov. 2, 1999 (PRIMEZONE) -- Situs Corp., a leader in the development of alternate drug delivery systems, today announced it has filed an Investigational New Drug Application...
LifePoint, Inc. Announces TV and Cable Appearances
April 14, 1999 11:30 ET
|
LifePoint, Inc.
LifePoint, Inc. is a development stage company focused on the commercialization of the flow immunosensor technology licensed from the Naval Research Laboratories. This proprietary technology, when...